top of page

MRTF/SRF PATHWAY INHIBITORS

We have discovered a series of compounds that inhibit the MRTF/SRF signaling axis and have found therapeutic benefits in melanoma and fibrosis

"Progress is made by trial and failure; the failures are generally a hundred times more numerous than the successes ; yet they are usually left unchronicled."

William Ramsay

bottom of page